Mobilizing Doulas to Empower Black Women in Post-partum Diabetes Prevention
Launched by VANDERBILT UNIVERSITY MEDICAL CENTER · May 22, 2020
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Mobilizing Doulas to Empower Black Women in Post-partum Diabetes Prevention," aims to help Black women who have had gestational diabetes during pregnancy lower their risk of developing Type 2 diabetes later on. Although both Black and White mothers have similar rates of gestational diabetes, Black mothers are more likely to develop Type 2 diabetes afterward. The researchers believe that providing additional support through trained community health workers, called "doula divas," while using a well-known diabetes prevention program (DPP), can improve the chances of Black mothers completing the program and making healthier lifestyle choices.
To be eligible for this trial, participants must be over 18 years old, speak English, have recently given birth, and have been diagnosed with gestational diabetes. They also need access to smartphone technology and identify as Black. Participants can expect to be part of a program that lasts one year, where some will receive the standard DPP, while others will receive the DPP along with extra support from the doula divas. This approach aims not only to empower these mothers but also to reduce the long-term health risks associated with diabetes, ultimately improving their health and well-being.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • \>18 years of age with English fluency
- • recently post-partum
- • clinical diagnosis of Gestational Diabetes Mellitus (GDM) using Carpenter Coustan criteria
- • access to smart phone technology Self identified Black race
- Exclusion Criteria:
- • \<18 years Preexisting type 2 diabetes
- • • Inability to follow up Non-black race
About Vanderbilt University Medical Center
Vanderbilt University Medical Center (VUMC) is a leading academic medical center located in Nashville, Tennessee, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, VUMC integrates cutting-edge scientific inquiry with patient-centered care, supporting a diverse array of studies aimed at enhancing medical knowledge and improving treatment outcomes. With a robust infrastructure and a multidisciplinary team of experts, VUMC fosters collaboration across various fields, ensuring the highest standards of safety and ethical considerations in its research endeavors. Through its dedication to medical discovery and education, VUMC plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nashville, Tennessee, United States
Patients applied
Trial Officials
Rolanda Lister
Principal Investigator
Vanderbilt University Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials